Just because many of the children in the current severe hepatitis outbreak were exposed to dogs, doesn’t mean dogs are the cause.
Academic rigor, journalistic flair
Articles on Hepatitis
Displaying 1 - 20 of 25 articles
The eyes can reveal many health problems, from high cholesterol to thyroid disease.
Scientists are urgently trying to find the cause of the global outbreak of severe liver disease in young children. So far, adenovirus seems to be the best lead.
While COVID-19 hasn’t been ruled out as a potential cause, the leading contender is actually adenovirus, a common infection in children that can lead to hepatitis on rare occasions.
DNA and mRNA vaccines produce a different kind of immune response than traditional vaccines, allowing researchers to tackle some previously unsolvable problems in medicine.
HBV cases in Nigeria point to a potential liver disease crisis. Prevention and care efforts are needed.
World Hepatitis Day is a clear call to improve efforts towards eliminating a disease that globally kills one person every 30 seconds.
New strategy helps build synthetic organs from scratch. This enabled the researchers to grow functioning liver tissue in the lab that could be transplanted into mice with liver disease.
Michael Houghton, an Edmonton-based virologist, was one of the recipients of this year’s Nobel Prize for physiology or medicine for the discovery of hepatitis C.
HIV/AIDS receives more funding than hepatitis, which is responsible for more deaths.
About 19 million Nigerians have hepatitis but most of them don’t know it.
St. Patrick’s Day is typically a day of drinking and revelry, if not reverence for Ireland’s patron saint. In this year’s subdued celebration environment, a biochemist suggests thanking our livers.
Babies in Australia have been vaccinated against hepatitis B since May 2000, but 240,000 Australians still live with the disease.
Organs from gay men or injecting drug users, often rejected for transplants, could safely be used, so long as donors test negative for infections such as HIV, and hepatitis B and C.
Many countries in sub-Saharan Africa have made vaccination and post-infection therapy available. But the number of those infected annually and dying from viral Hepatitis continues to be high.
No mother wants their baby to develop jaundice, but it turns out that they should probably be grateful.
Hepatitis A is a virus that infects the liver. Symptoms usually take 15-50 days to develop after initial infection and typically last for several weeks or sometimes longer.
Hepatitis viruses are serious infections that damage the liver. There is an urgent need to deal with increased Hepatitis B infections in Kenya.
Women have evolved to have stronger immunity than men. But this comes with downsides -
women are more likely to have autoimmune diseases due to their “reactive” immune systems.
Australia has been subsidising drugs to cure hepatitis C since March 2016. Unlike in many other countries, these are available to everyone with the disease and are much cheaper for our government.
Top contributors
-
Associate Research Scientist, African Population and Health Research Center
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW Sydney
-
Communications Officer, African Population and Health Research Center
-
Senior Research Associate, Cambridge Public Health; Associate Research Fellow, Cambridge Centre for Applied Research into Human Trafficking; Deputy Director, Intellectual Forum, Jesus College, University of Cambridge
-
Research associate, The Kirby Institute, UNSW Sydney
-
Research Fellow at Monash University, Monash University
-
Sociologue, chargée de recherche, Centre Population & Développement (CEPED), Institut de recherche pour le développement (IRD)
-
Professor of Immunology and Director of Research, Moi University
-
Professor, Molecular Immunology, Walter and Eliza Hall Institute
-
Senior research scientist, Walter and Eliza Hall Institute
-
Research Officer, Kenya Medical Research Institute
-
University of Nairobi
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Epidemiologist, WHO Collaboating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
